Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 51

Sort by

Sort Order Select

Journal Articles

Neurocognitive Impairment Predicts Poor Transition Outcomes Among Patients with Sickle Cell Disease

Anjelica C. Saulsberry, BA, Marita Partanen, PhD, Jerlym S. Porter, PhD MPH, Pradeep S. B. Podila, PhD MS, Jason R. Hodges, PhD MA, Allison A. King, MD MPH, PhD, Winfred Wang, MD, Xiwen Zhao, MSPH, Guolian Kang, PhD, Lisa M. Jacola, PhD ABPP-CN, Jane S. Hankins, MD MS

Blood (2019) 134 (Supplement_1): 519.

https://doi.org/10.1182/blood-2019-121617

Published: 2019

Journal Articles

TP53 Abnormality in Myelodysplastic Syndrome

Fei Huang, Yu Chen, Yuxing Zhu, Chun Qiao, Sixuan Qian, Jianyong Li, MD, Wenyi Shen, MD

Blood (2019) 134 (Supplement_1): 5410.

https://doi.org/10.1182/blood-2019-128054

Published: 2019

Journal Articles

Tumor Lysis Syndrome Management in Community Oncology Settings

Scott Howard, MD

Blood (2019) 134 (Supplement_1): 5875.

https://doi.org/10.1182/blood-2019-132266

Published: 2019

Journal Articles

Management of Delayed Elimination of High-Dose Methotrexate in Community Oncology Practices Can Mitigate Its Effect on Length of Hospital Stay, Treatment Dose-Density, Acute Kidney Injury, Dialysis, and Death

Scott Howard, MD, McKeon Tad Harry, PhD, Sfondouris John, PhD, Suresh Marada, PhD, Nicholas Napier, BS

Blood (2019) 134 (Supplement_1): 5889.

https://doi.org/10.1182/blood-2019-132098

Published: 2019

Journal Articles

Application of High-Throughput Sequencing in the Diagnosis of Inherited Immune-Thrombocytopenia from Children Chronic/Refractory ITP

Ma Jingyao, MD, Zhenping Chen, PhDMD, Huiqing LIU, Jialu Zhang, Hao GU, Runhui Wu, MD PhD

Blood (2019) 134 (Supplement_1): 86.

https://doi.org/10.1182/blood-2019-126771

Published: 2019

Journal Articles

Single Arm, Single Centre Prospective Study to Assess the Effect of Therapeutic Drug Monitoring (TDM) Based Dosage Adjustment of Posaconazole on the Incidence of Invasive Fungal Infections (IFIs) in AML Patients on Induction Chemotherapy on Posaconazole Prophylaxis

Manju Sengar, MD DM, Mounika Boppana, MD DM, Hasmukh Jain, MD DM, Vikram Gota, MD, Bhausaheb Bagal, MD DM, Anant Gokarn, MD, Murari Gujrar, MD, Madhavi Ambotkar, MD

Blood (2019) 134 (Supplement_1): 2600.

https://doi.org/10.1182/blood-2019-129948

Published: 2019

Journal Articles

An Analysis of Racial and Ethnic Backgrounds within the Casire International Cohort of Sickle Cell Disease Patients: Implications for Disease Phenotype and Clinical Research

Blood (2019) 134 (Supplement_1): 2305.

https://doi.org/10.1182/blood-2019-127613

Published: 2019

Journal Articles

PU.1 Enforces Hematopoietic Stem Cell Quiescence during Chronic Inflammation

James Chavez, BS, Jennifer L Rabe, BS, BA, Kelly Higa, MS, Dirk Loeffler, Ahmed Nouraiz, PhD, Taylor Mills, BA, Beau M Idler, Brett M. Stevens, PhD, Courtney Fleenor, PhD, Claus Nerlov, PhD, Hideaki Nakajima, MD, James Hagman, Timm Schroeder, PhD, Hyun Min Kim, PhD, Craig T Jordan, PhD, James DeGregori, Eric Pietras, PhD

Blood (2019) 134 (Supplement_1): 822.

https://doi.org/10.1182/blood-2019-129300

Published: 2019

Journal Articles

Disparities in Barriers and Facilitators of Acute Leukemia Diagnosis in Young Patients

Lucky Ding, BA, Ashley E Martin, MPH, Emma Canepa, MS, Erica Evans, MD, Richard Aplenc, MD PhD, Julia E Szymczak, PhD, Galen Joseph, PhD, Lena E. Winestone, MD MSHP

Blood (2019) 134 (Supplement_1): 3415.

https://doi.org/10.1182/blood-2019-124236

Published: 2019

Journal Articles

Safety of Intravenous Arginine Therapy in Children with Sickle Cell Disease Hospitalized for Vaso-Occlusive Pain: A Randomized Placebo-Controlled Trial in Progress

Claudia R. Morris, MD, Janet Figueroa, MPH, Amanda Watt, Kirshma Khemani, MD, Polly Kumari, MBBS, Morgan Barnett, MPH, Nitya Bakshi, MBBS, MS, Peter A. Lane, MD, Carlton Dampier, MD

Blood (2019) 134 (Supplement_1): 995.

https://doi.org/10.1182/blood-2019-122983

Published: 2019

Journal Articles

Non Invasive Evaluation of Hepatic Iron Concentration By Fibroscan in Transfusion-Dependent Egyptian Patients with Chronic Hemolytic Anemia

Amal El-Beshlawy, Dalia Omran, MD, Hala Mohsen Abdullatif, MD, Niveen Salama, MD, Mohamed Ahmed Abdel Naeem, MSc, Mona El ghamrawy, MD, Amina Abdel-Salam, MD

Blood (2018) 132 (Supplement 1): 1061.

https://doi.org/10.1182/blood-2018-99-118695

Published: 2018

Journal Articles

Quality of Life in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group

Rajaram Nagarajan, MD MS, Todd A Alonzo, PhD, Robert B Gerbing, MA, Donna Johnston, MD FRCPC, Richard Aplenc, MD PhD, E. Anders Kolb, MD, Soheil Meshinchi, MD PhD, Lamia Barakat, PhD, Lillian Sung, MD PhD

Blood (2018) 132 (Supplement 1): 4841.

https://doi.org/10.1182/blood-2018-99-112152

Published: 2018

Journal Articles

MBD4 : guardian of the epigenetic galaxy

Lambert Busque, Lucy A. Godley

Blood (2018) 132 (14): 1468–1469.

https://doi.org/10.1182/blood-2018-08-867044

Published: 2018

Journal Articles

Role of Health Literacy, Acculturation, and Socio-Demographics on Perception of Voluntariness during Informed Consent for Pediatric Leukemia Clinical Trials

Paula Aristizabal, MD MAS, Arissa K M, MD, Jesse Nodora, DrPh, Courtney Thornburg, MD, M. Elena Martinez, PhD

Blood (2017) 130 (Supplement 1): 3429.

https://doi.org/10.1182/blood.V130.Suppl_1.3429.3429

Published: 2017

Journal Articles

A Multicenter, Retrospective Data Collection Study on the Compassionate Use of a Plasma-Derived Factor X Concentrate to Treat Patients with Hereditary Factor X Deficiency

James N. Huang, MD, Ri Liesner, Chioma Akenezi, BSc, PgDip, Steven K. Austin, BMedSci, MBBS, Kaan Kavakli, MD

Blood (2017) 130 (Supplement 1): 3736.

https://doi.org/10.1182/blood.V130.Suppl_1.3736.3736

Published: 2017

Journal Articles

The Oncolytic Measles Virus Preferentially Infects p53 Abnormal Myeloma Cells

Anne Lok, MD, Geraldine Descamps, PhD, Benoit Tessoulin, MD, Philippe Moreau, Steven Le Gouill, MD PhD, Frederic Tangy, PhD, Martine Amiot, Catherine Pellat-Deceunynck, PhD

Blood (2016) 128 (22): 310.

https://doi.org/10.1182/blood.V128.22.310.310

Published: 2016

Journal Articles

Parent and Guardian Knowledge of Hematopoietic Cell Transplantation As a Treatment Option for Sickle Cell Disease

Alicia M Stallings, BA, Navneet S. Majhail, MD MS, Amy S Nowacki, PhD, Grace I. Onimoe, MD, Rabi Hanna, MD, Jillian Wen, B.S., Charles T Quinn, MD, Lewis L. Hsu, MD PhD, Connie M. Piccone, MD

Blood (2016) 128 (22): 1307.

https://doi.org/10.1182/blood.V128.22.1307.1307

Published: 2016

Journal Articles

Comprehensive Structured Transition Program with Dedicated Transition Navigator Reduced Lost to Follow-up and Improved Medication Adherence in Sickle Cell Disease and Thalassemia Adolescents and Young Adults

Brooke Allemang, MSW, RSW, Kate Allan, MSW, Colleen Johnson, BScN, MN/NP, Melina Cheong, BScN, MN/NP, Patrina Cheung, BSc, Isaac Odame, MBChB, FRCPath, FRCPC, Richard Ward, MSc, MRCP, FRCPath, Suzan Williams, MD MSc, FRCPC, Kevin H.M. Kuo, MD MSc, FRCPC

Blood (2016) 128 (22): 317.

https://doi.org/10.1182/blood.V128.22.317.317

Published: 2016

Journal Articles

Pediatric Hematologists' Clinical Practices and Perspectives of Hematopoietic Cell Transplantation As a Treatment Option for Sickle Cell Disease

Alicia M Stallings, BA, Navneet S. Majhail, MD MS, Amy S Nowacki, PhD, Grace I. Onimoe, MD, Rabi Hanna, MD, Connie M. Piccone, MD

Blood (2016) 128 (22): 3532.

https://doi.org/10.1182/blood.V128.22.3532.3532

Published: 2016

Journal Articles

Bleeding Events and Safety Outcomes in Patients with Hemophilia a with Inhibitors: A Prospective, Multicenter, Non-Interventional Study

Johnny Mahlangu, Johannes Oldenburg, Prof, Michael U Callaghan, MD, Midori Shima, MD PhD, Elena Santagostino, MD PhD, Michaela Lehle, PhD, Marianne Uguen, MSc, Ceri Hirst, PhD, Maggie Moore, RN, Michael Recht, MD PhD, Claudia Garcia, MD, Renchi Yang, MD PhD, Rebecca Kruse-Jarres, MD MPH

Blood (2016) 128 (22): 3800.

https://doi.org/10.1182/blood.V128.22.3800.3800

Published: 2016

NARROW

Neurocognitive Impairment Predicts Poor Transition Outcomes Among Patients with Sickle Cell Disease

TP53 Abnormality in Myelodysplastic Syndrome

Tumor Lysis Syndrome Management in Community Oncology Settings

Management of Delayed Elimination of High-Dose Methotrexate in Community Oncology Practices Can Mitigate Its Effect on Length of Hospital Stay, Treatment Dose-Density, Acute Kidney Injury, Dialysis, and Death

Application of High-Throughput Sequencing in the Diagnosis of Inherited Immune-Thrombocytopenia from Children Chronic/Refractory ITP

Single Arm, Single Centre Prospective Study to Assess the Effect of Therapeutic Drug Monitoring (TDM) Based Dosage Adjustment of Posaconazole on the Incidence of Invasive Fungal Infections (IFIs) in AML Patients on Induction Chemotherapy on Posaconazole Prophylaxis

An Analysis of Racial and Ethnic Backgrounds within the Casire International Cohort of Sickle Cell Disease Patients: Implications for Disease Phenotype and Clinical Research

PU.1 Enforces Hematopoietic Stem Cell Quiescence during Chronic Inflammation

Disparities in Barriers and Facilitators of Acute Leukemia Diagnosis in Young Patients

Safety of Intravenous Arginine Therapy in Children with Sickle Cell Disease Hospitalized for Vaso-Occlusive Pain: A Randomized Placebo-Controlled Trial in Progress

Non Invasive Evaluation of Hepatic Iron Concentration By Fibroscan in Transfusion-Dependent Egyptian Patients with Chronic Hemolytic Anemia

Quality of Life in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group

MBD4 : guardian of the epigenetic galaxy

Role of Health Literacy, Acculturation, and Socio-Demographics on Perception of Voluntariness during Informed Consent for Pediatric Leukemia Clinical Trials

A Multicenter, Retrospective Data Collection Study on the Compassionate Use of a Plasma-Derived Factor X Concentrate to Treat Patients with Hereditary Factor X Deficiency

The Oncolytic Measles Virus Preferentially Infects p53 Abnormal Myeloma Cells

Parent and Guardian Knowledge of Hematopoietic Cell Transplantation As a Treatment Option for Sickle Cell Disease

Comprehensive Structured Transition Program with Dedicated Transition Navigator Reduced Lost to Follow-up and Improved Medication Adherence in Sickle Cell Disease and Thalassemia Adolescents and Young Adults

Pediatric Hematologists' Clinical Practices and Perspectives of Hematopoietic Cell Transplantation As a Treatment Option for Sickle Cell Disease

Bleeding Events and Safety Outcomes in Patients with Hemophilia a with Inhibitors: A Prospective, Multicenter, Non-Interventional Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only